| HOME >> BIOLOGY >> TECHNOLOGY |
Share Breakdown Number of Pipeline Drugs by Indication 64
Bioinformatics 64
Proteomics 65
Biochips 65
Challenges Faced by US Biotechnology Market 65
1b. CANADA 66
Market Overview 66
Revenues and R&D Expenditures Plunge 66
Table 14: Canadian Biotechnology Industry (2010): Funds
Raised by Biotechnology Clusters 67
1c. MEXICO 68
End-Use Industries 68
Bio-Pharmaceuticals 68
Food Biotechnology 68
Environmental Biotechnology 68
2. JAPAN 69
Biotechnology Market Overview 69
Japanese Companies Expand Business Operations 69
End-Use Industries 70
Medical Biotechnology and Healthcare 70
Biosimilars 70
Food Biotechnology Industry 70
Environmental Biotechnology 70
3. EUROPE 71
Industry Overview 71
Table 15: European Biotechnology Industry (2010): Number of
Biotechnology Product Candidates by Country 72
Finance Scenario 72
Table 16: VC Fundings in US and Europe (2010): Percentage
Share Breakdown by Indication 73
Regulatory and Policy Landscape 73
Current & Future Analysis 73
Table 17: European Biotechnology Market by Country/Region -
France, Germany, Italy, UK, Spain and Rest of Europe - With
Annual Revenues in US$Million for Years 2010 through 2015 74
Table 18: European Biotechnology Market (2011 & 2015):
Percentage Breakdown of Value Sales by Country/Region 75
Table 19: Number of Public Biotechnology Companies in Europe
by Country (2010) 75
3a. DENMARK 76
3b. FRANCE 77
Overview 77
French Government Takes Active Measures to Boost Financing 77
Challenges and Outlook 77
3c. GERMANY 78
Overview 78
Government Support 78
3d. ITALY 79
Overview 79
3e. THE NETHERLANDS 80
Market Prospects 80
3f. POLAND 81
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |